Rational designing of glyco-nanovehicles to target cellular heterogeneity

The aberrant expression of endocytic epidermal growth factor receptors (EGFRs) in cancer cells has emerged as a key target for therapeutic intervention. Here, we describe for the first time a state-of-the-art design for a heparan sulfate (HS) oligosaccharide-based nanovehicle to target EGFR-overexpr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Prashant, Shanthamurthy, Chethan D., Chaudhary, Preeti Madhukar, Kikkeri, Raghavendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179433/
https://www.ncbi.nlm.nih.gov/pubmed/34163672
http://dx.doi.org/10.1039/d1sc00140j

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179433/
https://www.ncbi.nlm.nih.gov/pubmed/34163672
http://dx.doi.org/10.1039/d1sc00140j

Ejemplares similares